The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Nicotinic Acetylcholine Receptors in the Mesolimbic Pathway: Primary Role of Ventral Tegmental Area α6β2* Receptors in Mediating Systemic Nicotine Effects on Dopamine Release, Locomotion, and Reinforcement
Open accessAbstract
α6* nicotinic acetylcholine receptors (nAChRs) are highly and selectively expressed by mesostriatal dopamine (DA) neurons. These neurons are thought to mediate several behavioral effects of nicotine, including locomotion, habit learning, and reinforcement. Yet the functional role of α6* nAChRs in midbrain DA neurons is mostly unknown. The aim of this study was to determine the composition and in vivo functional role of α6* nAChR in mesolimbic DA neurons of male rats. Immunoprecipitation and immunopurification techniques coupled with cell-specific lesions showed that the composition of α6* nAChR in the mesostriatal system is heterogeneous, with (non-α4)α6β2* being predominant in the mesolimbic pathway and α4α6β2* in the nigrostriatal pathway. We verified whether α6* receptors mediate the systemic effects of nicotine on the mesolimbic DA pathway by perfusing the selective antagonists α-conotoxin MII (CntxMII) (α3/α6β2* selective) or α-conotoxin PIA (CntxPIA) (α6β2* selective) into ventral tegmental area (VTA). The intra-VTA perfusion of CntxMII or CntxPIA markedly decreased systemic nicotine-elicited DA release in the nucleus accumbens and habituated locomotion; the intra-VTA perfusion of CntxMII also decreased the rate of nicotine infusion in the maintenance phase of nicotine, but not of food, self-administration. Overall, the results of these experiments show that the α6β2* nAChRs expressed in the VTA are necessary for the effects of systemic nicotine on DA neuron activity and DA-dependent behaviors such as locomotion and reinforcement, and suggest that α6β2*-selective compounds capable of crossing the blood–brain barrier may affect the addictive properties of nicotine and therefore be useful in the treatment of tobacco dependence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Similarly, conotoxins selective for α6/β2 Ã nAChRs disrupt nicotine self-administration in the rat when infused into the VTA (Gotti et al. 2010) and following selfadministration training, these conotoxins decrease the motivation to lever press for nicotine on a progressive ratio schedule (Brunzell et al. 2010).”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as Gotti et al. 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
LIGAND: A versatile computerized approach for characterization of ligand-binding systems
Munson, P. J., & Rodbard, D. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90515-1 · Cited by 8,373
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
AChE-stained horizontal sections of the rat brain in stereotaxic coordinates
Paxinos, G., WATSON, C. R. R., & Emson, P. C. (1980) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(80)90021-7 · Cited by 4,501
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Self-citationBrain nicotinic acetylcholine receptors: native subtypes and their relevance
Gotti, C., Zoli, M., & Clementi, F. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.004 · Cited by 882
Self-citationWise, R. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00965-0 · Cited by 881
Nicotinic Receptors at the Amino Acid Level
Corringer, P., Novère, N. G. L., & Changeux, J. (2000) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.431 · Cited by 832
Corrigall, W. A., Coen, K. M., & Adamson, K. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)90401-4 · Cited by 740
Role of dopamine in the behavioural actions of nicotine related to addiction
Chiara, G. D. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00122-9 · Cited by 698
Cited by
Sorted by citations
Items 201–228 of 228
Neurobiology and Mechanisms of Nicotine Addiction
Gogineni, H. P., Sachs, D. P. L., & Brunzell, D. H. (2023) · Respiratory medicine · doi:10.1007/978-3-031-24914-3_3 · Cited by 2
Castro, E. M., Nguyen, M., Georgy, D. H., & Lotfipour, S. (2025) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntaf147 · Cited by 1
Hahn, B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813035-3.00038-1 · Cited by 1
Effects of nicotine on DARPP-32 and CaMKII signaling relevant to addiction
Lee, A. M., & Picciotto, M. R. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.09.002 · Cited by 1
Soll, L. G. (2013) · eScholarship@UMassChan · doi:10.13028/m2ng64
Schifirnet, E. (2010) · Human Biology
Evaluación de la Nicotina Como Estímulo Aversivo11Proyecto apoyado por: DGAPA PAPIIT IN-302512
Sánchez-Castillo, H., Olivares, G. L. F., Reyes, A. K. R., Paz-Trejo, D. B., & Herrera, F. M. (2015) · Acta de Investigación Psicológica · doi:10.1016/s2007-4719(15)30011-9
Involvement of the Cholinergic System in Levodopa-Induced Dyskinesia
Quik, M., Bordia, T., Zhang, D., & Perez, X. A. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6503-3_16
Nicotinic Acetylcholine Receptors in Alzheimer’s and Parkinson’s Disease
Dineley, K. T. (2014) · The Receptors · doi:10.1007/978-1-4939-1167-7_19
Nicotine Assessment as an Aversive Stimulus
Sánchez-Castillo, H., Olivares, G. L. F., Reyes, A. K. R., Paz-Trejo, D. B., & Miranda, F. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
A Novel Mechanism for Nicotinic Acetylcholine Receptor Antagonist-Induced Cancer Cell Cytotoxicity
Clarke, M. R. (2016) · Otago University Research Archive (University of Otago)
The Role of Medial Habenula-Interpeduncular Nucleus Pathway in Anxiety: A Dissertation
Pang, X.-Y. (2015) · eScholarship@UMassChan · doi:10.13028/m2vp49
Ngolab, J. (2015) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2730b
The Effects of Binge-Like Sucrose Consumption on the Mesolimbic Reward Pathway in the Brain
Shariff, M. R. (2017) · Queensland University of Technology · doi:10.5204/thesis.eprints.107900
Nicotinic Cholinergic Mechanisms in Alcohol Abuse and Dependence
Rahman, S., & Bell, R. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813125-1.00044-1
Maggio, S. E. (2019) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2019.395
Sugar consumption and expression of neuronal nicotinic receptors in the Nucleus Accumbens
Ali, S. A. (2021) · Queensland University of Technology · doi:10.5204/thesis.eprints.208972
Azarn, L., Maskos, U., Changeux, J., Dowell, C. D., Christensen, S. B., Biasi, M. D., & McIntosh, J. M. (2010) · The FASEB Journal · doi:10.1096/fj.10.166272
Ödül Değerinde Kimyasal Dopamin ve İşlevleri
Pençe, M. E. (2024) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3130
Xu, W., Wang, M., Li, X., He, R., Ding, R., Bao, J., Zhangsun, D., & Luo, S. (2025) · Marine Drugs · doi:10.3390/md23030109
Hernández-Colín, A. E., Canseco-Alba, A., & Rodrı́guez–Manzo, G. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06903-x
Raval, N. R., Calakos, K. C., Zheng, M.-Q., Huttner, A. J., Esterlis, I., Huang, Y. H., Calhoun, V. D., Picciotto, M. R., Cosgrove, K., & Hillmer, A. T. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-025-02311-z
Understanding Nicotine Addiction: Personalizing Therapy for Smoking Cessation
Stein, J., Minkin, R., Parikh, M. A., RAFIAA, M., Frishman, W. H., & Peterson, S. J. (2026) · Cardiology in Review · doi:10.1097/crd.0000000000001221
An, B., Tang, Z., Hu, K., Wei, P.-C., Zhangsun, D.-T., Zhu, X.-P., Yu, J.-P., & Luo, S.-L. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.111070
BindingDB (2014) · UC San Diego · doi:10.7270/q2s183zx
Role of α6 nAChRs in Ethanol Modulation of VTA Neurons
Shin, S. I. (2014) · ScholarsArchive (Brigham Young University)
Metadata
- Authors
- Gotti, C., Guiducci, S., Tedesco, V., Corbioli, S., Zanetti, L., Moretti, M., Zanardi, A., Rimondini, R., Mugnaini, M., Clementi, F., Chiamulera, C., & Zoli, M.
- Affiliations
- University of Milan (IT)
- University of Modena and Reggio Emilia (IT)
- University of Verona (IT)
- GlaxoSmithKline (Italy) (IT)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2010-04-14
- Volume
- 30
- Issue
- 15
- Pages
- 5311-5325
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6632743
- OpenAlex
- W2051648601
- Cited by
- 226
- References
- 64
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 7 · 2023: 8 · 2022: 5 · 2021: 3 · 2020: 9 · 2019: 12 · 2018: 10 · 2017: 9 · 2016: 15 · 2015: 21 · 2014: 26 · 2013: 30 · 2012: 29
- FWCI
- 11.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by-nc-sa)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Funders
- GlaxoSmithKline
- Compagnia di San Paolo
- Fondazione Cariplo
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- nicotinic acetylcholine receptors, ventral tegmental area, mesolimbic dopamine system, nicotine, dopamine release, nucleus accumbens, locomotion, nicotine self-administration, nicotine reinforcement, alpha-conotoxin MII, receptor heterogeneity, nicotine dependence, tobacco dependence
- MeSH terms
- Animals, Corpus Striatum, Dopamine, Feeding Behavior, Male, Mesencephalon, Motor Activity, Neural Pathways, Neurons, Nicotine, Nucleus Accumbens, Receptors, Nicotinic, Reinforcement, Psychology, Self Administration, Rats, Sprague-Dawley, Ventral Tegmental Area, Nicotinic Agonists, Nicotinic Antagonists, Conotoxins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
